DeDora Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
DeDora Capital's BMRN Position: Q3 2026 in Review
DeDora Capital opened a new position in BioMarin Pharmaceuticals (BMRN) in Q3 2026: 242 shares worth $14.5K. The stake represents ﹤0.01% of the portfolio and ranks #277 among its holdings. This is a return to the name: DeDora Capital previously reported a position in BMRN as recently as Q1 2022.
DeDora Capital first reported a position in BMRN in Q1 2022 and has held it in 2 quarters since. 567 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- DeDora Capital held 242 shares of BioMarin Pharmaceuticals worth $14.5K as of Q3 2026.
- BioMarin Pharmaceuticals was a new DeDora Capital position in Q3 2026.
- BioMarin Pharmaceuticals made up ﹤0.01% of DeDora Capital's portfolio in Q3 2026, its #277 holding.
- DeDora Capital first reported a position in BioMarin Pharmaceuticals in Q1 2022 and has held it in 2 quarters since.
- 567 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on DeDora Capital's 13F filing for Q3 2026, filed 26 Oct 2026.